Biosyntrx
(800) 688-6815
Article
Friday Pearls
Mitochondrial clean-up to prevent and treat Age Related Macular Degeneration. Acetyl-L-Cartinine, CoQ10, Vitamin E
August 29, 2003
A histopathologic study recently published in the September 2003 peer-reviewed issue of Ophthalmologica shows that nutrient compounds, which improve mitochondrial functions, show beneficial effects in preventing and treating Age Related Macular Degeneration (AMD).
Fourteen patients affected by early AMD were treated with a
multiple nutrient formulation containing acety -L-carnitine, coenzyme
Q10 and vitamin E and EFAs, while a matched group affected by early AMD
were treated with vitamin E only. In the multiple nutrient treatment
group, all the visual functions showed improvement, which was evident
after three months of treatment and remained nearly stationary by the
end of 24 months. The same tests in the control group showed slow
progressive worsening. The findings suggest that the blend of these
specific nutrients can improve retinal functions in early AMD.
Ellen Troyer, MT MA - Biosyntrx Chief Research Officer
Spencer Thornton, MD - Biosyntrx President
PEARL
Based on an extensive body of peer-reviewed mitochondria research
literature, Biosyntrx included these (albeit expensive) specific
nutrients in our full body Macula Complete formulation. To our
knowledge, no other AMD formulation available in today's market place
appropriately addresses the pathophysiology of cellular mitochondria
and the relationship to eye disease.
References
Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study. Feher J, Papale A, et al. Ophthalmologica, 2003 Sept-Oct;217(5):351-7
